TY - JOUR
T1 - Membrane Interactome of a Recombinant Fragment of Human Surfactant Protein D Reveals GRP78 as a Novel Binding Partner in PC3, a Metastatic Prostate Cancer Cell Line
AU - Thakur, Gargi
AU - Sathe, Gajanan
AU - Kundu, Indra
AU - Biswas, Barnali
AU - Gautam, Poonam
AU - Alkahtani, Saad
AU - Idicula-Thomas, Susan
AU - Sirdeshmukh, Ravi
AU - Kishore, Uday
AU - Madan, Taruna
N1 - Funding Information:
We thank ICMR and Dr. Smita Mahale, Director, ICMR-National Institute for Research in Reproductive Health (ICMR-NIRRH), Mumbai, for intramural funding (Accession number 921). We thank Mr. Vaibhav Shinde for his support to enhance resolution of the figures. SA was funded by Researchers Supporting Project (RSP-2020/26) King Saud University, Riyadh.
Publisher Copyright:
© Copyright © 2021 Thakur, Sathe, Kundu, Biswas, Gautam, Alkahtani, Idicula-Thomas, Sirdeshmukh, Kishore and Madan.
PY - 2021/1/19
Y1 - 2021/1/19
N2 - Surfactant protein-D (SP-D), a member of the collectin family has been shown to induce apoptosis in cancer cells. SP-D is composed of an N-terminal collagen-like domain and a calcium-dependent carbohydrate recognition domain (CRD). Recently, we reported that a recombinant fragment of human SP-D (rfhSP-D), composed of homotrimeric CRD region, induced intrinsic apoptotic pathway in prostate cancer cells. Here, we analyzed the membrane interactome of rfhSP-D in an androgen-independent prostate cancer cell line, PC3, by high resolution mass spectrometry and identified 347 proteins. Computational analysis of PPI network of this interactome in the context of prostate cancer metastasis and apoptosis revealed Glucose Regulated Protein of 78 kDa (GRP78) as an important binding partner of rfhSP-D. Docking studies suggested that rfhSP-D (CRD) bound to the substrate-binding domain of glycosylated GRP78. This was further supported by the observations that human recombinant GRP78 interfered with the binding of rfhSP-D to anti-SP-D polyclonal antibodies; GRP78 also significantly inhibited the binding of recombinant full-length human SP-D with a monoclonal antibody specific to the CRD in a dose-dependent manner. We conclude that the interaction with rfhSP-D is likely to interfere with the pro-survival signaling of GRP78.
AB - Surfactant protein-D (SP-D), a member of the collectin family has been shown to induce apoptosis in cancer cells. SP-D is composed of an N-terminal collagen-like domain and a calcium-dependent carbohydrate recognition domain (CRD). Recently, we reported that a recombinant fragment of human SP-D (rfhSP-D), composed of homotrimeric CRD region, induced intrinsic apoptotic pathway in prostate cancer cells. Here, we analyzed the membrane interactome of rfhSP-D in an androgen-independent prostate cancer cell line, PC3, by high resolution mass spectrometry and identified 347 proteins. Computational analysis of PPI network of this interactome in the context of prostate cancer metastasis and apoptosis revealed Glucose Regulated Protein of 78 kDa (GRP78) as an important binding partner of rfhSP-D. Docking studies suggested that rfhSP-D (CRD) bound to the substrate-binding domain of glycosylated GRP78. This was further supported by the observations that human recombinant GRP78 interfered with the binding of rfhSP-D to anti-SP-D polyclonal antibodies; GRP78 also significantly inhibited the binding of recombinant full-length human SP-D with a monoclonal antibody specific to the CRD in a dose-dependent manner. We conclude that the interaction with rfhSP-D is likely to interfere with the pro-survival signaling of GRP78.
KW - apoptosis
KW - GRP78
KW - innate immunity
KW - interactome analysis
KW - prostate cancer
KW - signaling
KW - surfactant protein D
UR - http://www.scopus.com/inward/record.url?scp=85100524756&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2020.600660
DO - 10.3389/fimmu.2020.600660
M3 - Article
C2 - 33542717
AN - SCOPUS:85100524756
SN - 1664-3224
VL - 11
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 600660
ER -